A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province

SuxiaLuo

Status: Unknown

Conditions: Carcinoma;Blood

Treatments: Drug: Herombopag

Study type: Observational

Funder types: Other

Identifiers

NCT05130424

HNHQRWS

Details and patient eligibility

About

To observe and evaluate the safety and effectiveness of herombopag in the treatment of thrombocytopenia-related diseases in Henan Province

Full description

This study is designed as a real-world study on the treatment of thrombocytopenia-related diseases with Herombopag, to observe and analyze the safety and efficacy of Herombopag for thrombocytopenia-related diseases in the real world.

Enrollment: 498 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Thrombocytopenia related diseases;
2. Volunteer to join this study and sign an informed consent form;
3. Clinical evaluation can benefit from Herombopag.

Exclusion criteria

1. Those who have been confirmed to be allergic to Herombopag and/or its excipients;
2. Pregnant or breastfeeding women;
3. Except for patients with contraindications to Herombopag;
4. Doctors evaluate patients who are not suitable for inclusion.